BLSH vs DOCN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 30, 2026
BLSH
DOCN
Investment Advisor Scores
DOCN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BLSH | DOCN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 58.8235 | 76.3359 | BLSH |
| PEG Ratio | 0 | 1.5379 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 68.8% | 28.6% | BLSH |
| Earnings Growth | 0.0% | -24.5% | BLSH |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 44.0/100 | 36.9/100 | BLSH |
| Profit Margin | 0.0% | 23.3% | DOCN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | BLSH |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BLSH
MarkupPrice above SMA50, rising 50-day trend (19.2% over 20 days), RSI 50
DOCN
NeutralMixed signals - no dominant trend phase, RSI 58
Fundamentals Snapshot
| Metric | BLSH | DOCN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.6 | 75.9 |
| Trailing P/E | — | 60.6 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.7% | 0.3% |
| Gross Margin | 1.0% | 0.6% |
| Operating Margin | -3.1% | 0.1% |
| EPS | -10.00 | 2.20 |
| Dividend Yield | — | — |